PKCα was found to promote colon cancer [9] and breast and ovarian cancer [10], and PKCβ was implicated in the progression of breast cancer [11], colon cancer [12], prostate cancer [13], and glioblastoma [14]. Here, PRKCB is linked to malignant colon neoplasm.